neuropeptide Y
Peptideexperimental
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
1
Earliest trial started Jan 1, 2010 (NCT00748956)
Timeline
Indications
Approved for
Mechanism of action
NPY1R agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- neuropeptide y
- neuropeptide y
- npy
- npy
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04838678 | Early Phase 1 (Phase 1) | Jul 18, 2021 | The University of Texas, Dallas |
| NCT04071600 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2019 | New York Medical College, United States Army, Westchester Medical Center |
| NCT02639637 | Phase 4 | Dec 1, 2015 | Vanderbilt University |
| NCT01533519 | Phase 1 | Dec 1, 2012 | Icahn School of Medicine at Mount Sinai |
| NCT00748956 | Phase 2 | Jan 1, 2010 | Icahn School of Medicine at Mount Sinai |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 2 | 2 | 2 | 2010 |
| New York Medical College | Academic/Hospital | 1 | 1 | 1 | 2019 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 1 | 1 | 2021 |
| United States Army | Government | 1 | 0 | 1 | 2019 |
| Vanderbilt University | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Westchester Medical Center | Academic/Hospital | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1